Zastosowanie komórek macierzystych w leczeniu cukrzycy

1. Roszek K., Komoszyński M. Kontrola i kierunki ró?nicowania komórek macierzystych krwi p?powinowej oraz ich zastosowanie terapeutyczne. Post. Hig. Med. Do?w. 2008; 62: 660–667.

2. Becker A.J., McCulloch E.A., Till J.E. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197: 552–454.

3. Olszewska-S?onina D., Styczyński J., Drewa T., Czajkowski R. Komórki niezró?nicowane – ?ród?a i plastyczno??. Adv. Clin. Exp. Med. 2006; 15, 3: 497 –503.

4. Alison M.R., Poulson R., Forbes S. Wright N.A. An introduction to stem cells. J. Patho1. 2002; 197: 419–423.

5. Kucia M., Majka M., Ratajczak M.Z. Plastyczno?? nieembrionalnych komórek macierzystych: fakt czy artefakt? Post. Biol. Komórki 2003; l30 (Supl. 21): 3–16.

6. Bajek A., Olkowska J., Drewa T. Mezenchymalne komórki macierzyste narz?dziem terapeutycznym w regeneracji tkanek i narz?dów. Post. Hig. Med. Do?w. (online) 2011; 65: 127.

7. Ratajczak M.Z., Zuba-Surma E., Ratajczak J. Komórki macierzyste – blaski i cienie. Acta Haematol. Pol. 2009; 40: 289–303.

8. Bana? A. Komórki macierzyste – perspektywy i zagro?enia. Prz. Med. Uniw. Rzesz. 2010, 2, 117–127.

9. Suzuki A., Nakauchi H., Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using fl ow-cytometric cell sorting. Diabetes 2004; 53: 2143 –2152.

10. Pertopalvovskaia M., Rosenberg L. Identifi cation and characterization of small cells in the adult pancreas: potential progenitor cells? Cell Tissue Res. 2002; 310: 51–58.

11. Yatoh S., Dodge R., Akashi T., Omer A., Sharma A., Weir G.C. Diferentiation of affi nity-purifi ed human pancreatic duet cell s to beta-cells. Diabetes 2007; 56: 1802 –1809.

12. Couri C.E., Voltarelli J.C. Potential role of stem cell therapy in type l diabetes mellitus. Arcq. Bras. Endocrinol. Metab. 2008; 52: 407–415.

13. Jezierska-Wo?niak K., Nosarzewska D., Tutas A., Miko?ajczyk A., Okliński M., Jurkowski K.M. Wykorzystanie tkanki t?uszczowej jako ?ród?a mezenchymalnych komórek macierzystych. Post. Hig. Med. Do?w. 2010; 64: 326–332.

14. Li H.Y., Chen Y.J., Chen S.J. i wsp. Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells. J. Pharmacol. Exp. Ther. 2010; 335: 818–822.

15. Tutak M., Duka?a J., Sporniak-Tutak K. Tkanki z?ba – potencjalne ?ród?o komórek macierzystych. Czas. Stomatol. 2006; 59: 451–457.

16. Lin H.Y., Tsai C.C., Chen L.L., Chiaou S.H., Wang Y.I., Hung J. Fibronetic and laminin promote diff erentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK. J. Biomed. Sci. 2010; 17: 56.

17. Lee. D.D., Grossman E., Chong A.S., Werner A. Cellular therapies for type 1 diabetes. Horm. Metab. Res. 2008; 40: 147–154.

18. Guo T., Hebrok M. Stem cells to pancreatic b-cells: new sources for diabetes cell therapy. Endocr. Rev. 2009; 30: 214–227.

19. Jiang W., Shi Y., Zhao D. i wsp. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007; 17: 333–344.

20. Kang E.M., Zickler M.M., Bums S. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to signifi cant islet cells regeneration once disease is established. Exp. Hematol. 2005; 33: 699–705.

21. Ende N., Chen R., Reddi A.S. EfIect of human umbilical blood cell on glycemia and insulitis in type 1 diabetic mice. Biochem. Biophys. Res. Commun. 2004; 325: 665–669.

22. Chen L.B., Jiang X.B., Yang L. Diff erentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J. Gastroenterol. 2004; 10: 3016–20.

23. Lee R.H., Seo M.J., Reger R.L. Multipotent stromal cells from human marrow home to promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 2006; 103: 17438–17443.

24. Fiotina P., Jurewicz M., Augello A. i wsp. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 2009; 183: 993–1004.

25. Ende N., Chen R., Reddi A.S. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem. Biophys. Res. Commun. 2004; 321: 168–171.

26. Abdi R., Fiorina P., Adra C.N, Atkinson M., Sayegh M.H. Immunomodulation by mesenchymal stem cells. A potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 58:

27. Ezquer F.E., Ezquer M.E., Parrau D.B., Caprio D., Yanez A.J., Conget P.A. Systemic administration of multipotent mesenchymal stem cells reverts hyprglycemia and prevents nephropathy in type l diabetic mice. Biol. Blood. Marrow. Transplant. 2008; 14: 631–640.

28. Volarevic V., Arsenijevic N., Lukic L.M., Stojkovic M. Concise Review: Mesenchymal stem cells treatment of the complications of diabetes mellitus. Stem. Cells 2011; 29: 5–10.

29. Lee J.S., Hong J.M., Moon G.J. A long- -term follow-up study of intravenous autologus mesenchymal stem cells transplantation in patients with ischemic stroke. Stem. Cells 2010; 28: 1099–1106.

30. Sieradzki J. Kardiomiopatia cukrzycowa. Diabetol. Prakt. 2001; 2(4): 249–254.

31. Poornima G., Parikh P., Shannon R.P. Diabetic cardiomiopathy. The search for a unitying hypothesis. Circ. Res. 2006; 98: 596–605.

32. Liao Y.H., Verchere C.B., Warnock G.L. Adult stem or progenitor cells in treatment for type l diabetes: current progress. Can. J. Surg. 2007; 50: 137–142.

33. Wegner M., Pietrucha T., Pioruńska- Stolzmann M. Terapia komórkowa w leczeniu cukrzycy typu 1 – czy będzie możliwa? Diabet. Prakt. 2009; 10(4): 157–161.

34. Liew C.G. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols. Rev. Diabet. Stud. 2010; 7(2): 82–92.

35. Shibata T., Naruse K., Kamiya H. Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polineuropathy in rats. Diabetes 2008; 57: 3099–3107.

36. Tolar J., Nauta A.J., Osbom M.J. Sarcoma derived from cultured mesenchymal stem cells. Stem. Cells 2007; 25: 371–379.

37. Yechoor V., Chan L. Minireview: betacell replacement therapy for diabetes in the 21st century: manipulation of cells fate by directed ditferentiation. Mol. Endocrinol. 2010, 24(8); 1501–1511.